Simple Summary Malignant pleural mesothelioma (MPM) is an aggressive cancer linked to
asbestos exposure with an extremely poor outcome. Despite the recent approval of immune …

Ranked high in worldwide growing health issues, pleural diseases affect approximately one
million people globally per year and are often correlated with a poor prognosis. Among …

In the relentless battle against mesothelioma, a rare and aggressive form of cancer with a
dire prognosis, this research explores the transformative potential of ensemble learning …

Abstract Background/Aim: Mesotheliomas are tumors similar to, and probably derived from,
mesothelial cells. They carry acquired chromosomal rearrangements, deletions affecting …

Simple Summary The search for precision medicine applications in mesotheliomas (MM) is
taking its first steps. After platinum and pemetrexed chemotherapy, the treatment for …

Malignant pleural mesothelioma (MPM) represents a significant clinical challenge due to
limited therapeutic options and poor prognosis. Beyond mere survivorship, setting up an …

Simple Summary Pleural mesothelioma is a neoplastic disease originating from
mesothelium and is commonly associated with asbestos exposure. Despite the progress …

Pleural mesothelioma is a rare and aggressive cancer that affects the pleura. In recent
years, there has been increasing interest and attention in detecting and diagnosing early …

Abstract Purpose of Review Pleural mesothelioma (PM) is a rare but fatal cancer of the
pleural surface. Most patients have a poor prognosis, despite treatment advances which …

Pleural mesothelioma is a very aggressive malignancy that arises from the pleural
mesothelial cell lining and is linked strongly to prior asbestos exposure. The ban on …